Sleep Apnea Syndromes Clinical Trial
— Meta IAHflowOfficial title:
Apnoea-Hypopnoea-Indices Determined Via Continuous Posi-tive Airway Pressure (AHI-CPAPflow) Versus Those Determined by Polysomnography (AHI-PSGgold): a Protocol for a Systematic Review and Meta-analysis
NCT number | NCT04526366 |
Other study ID # | RECHMPL20_0395 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | March 31, 2021 |
Est. completion date | May 31, 2021 |
Verified date | October 2021 |
Source | University Hospital, Montpellier |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
To date, no published systematic review and meta-analysis has compared AHI-CPAPflow and AHI-PSGgold. Therefore, the primary objective of this study is to compare published data for AHI-PSGgold and AHI-CPAPflow in patients treated by CPAP.
Status | Completed |
Enrollment | 1 |
Est. completion date | May 31, 2021 |
Est. primary completion date | May 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - All (full scientific) study designs and publication types written in English and reporting Bland-Altman test results (or other tests suggesting the presence of the required data) between simultaneous, paired, polysomnography (PSG)-derived AND Continuous Positive Airway Pressure (CPAP)-derived data describing sleep disordered breathing. Exclusion Criteria: - Duplicates - Does not refer to a full scientific article (e.g. case reports are excluded). - Meta-analysis - Paediatric populations (populations <18 years are excluded). - Absence of appropriate paired results: synchronized polysomnography (PSG)-derived AND Continuous Positive Airway Pressure (CPAP)-derived data must be reported for =1 of the following measures: Apnoea-Hypopnoea-Indices (AHI), Apnoea-Indices (AI), Hypopnoea-Indices(HI), respiratory disturbance index (RDI), respiratory effort related arousals (RERA). - Absence of appropriate test comparing paired results: the study must use =1 of the fol-lowing tests to compare the previously mentioned PSG-vs-CPAP-derived data: a bland-altman or correlation test, other conformity tests, tests of differences in centrality. - Inappropriate PSG scoring 1: PSG-derived variables must be coded following the American Academy of Sleep Medicine 2007 (or more recent) guidelines. - Inappropriate PSG scoring 2: PSG-derived variables must be scored manually. - Inappropriate PSG scoring 3: oxygen desaturation level used for scoring must be mentioned and at 3% or 4%. - Inappropriate CPAP description: brand/device names must be mentioned. |
Country | Name | City | State |
---|---|---|---|
France | University Hospitals of Montpellier | Montpellier |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Montpellier |
France,
Bertelli F, Suehs CM, Mallet JP, Rotty MC, Pepin JL, Gagnadoux F, Matzner-Lober E, Bourdin A, Molinari N, Jaffuel D. Apnoea-hypopnoea indices determined via continuous positive airway pressure (AHI-CPAP(flow)) versus those determined by polysomnography (AHI-PSG(gold)): a protocol for a systematic review and meta-analysis. BMJ Open. 2021 May 10;11(5):e044499. doi: 10.1136/bmjopen-2020-044499. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The mean difference between AHI-CPAPflow and AHI-PSGgold | AHI-CPAPflow = Apnoea-Hypopnoea-Indices Determined Via Continuous Positive Airway Pressure AHI-PSGgold = Apnoea-Hypopnoea-Indices Determined by Polysomnography | Day 0 | |
Primary | The standard deviation for the mean difference between AHI-CPAPflow and AHI-PSGgold | Day 0 | ||
Secondary | The mean difference between AI-CPAPflow and AI-PSGgold | AI-CPAPflow = Apnoea--Indices Determined Via Continuous Positive Airway Pressure AI-PSGgold = Apnoea--Indices Determined by Polysomnography | Day 0 | |
Secondary | The standard deviation for the mean difference between AI-CPAPflow and AI-PSGgold | Day 0 | ||
Secondary | The mean difference between HI-CPAPflow and HI-PSGgold | HI-CPAPflow = Hypopnoea--Indices Determined Via Continuous Positive Airway Pressure HI-PSGgold = Hypopnoea--Indices Determined by Polysomnography | Day 0 | |
Secondary | The standard deviation for the mean difference between HI-CPAPflow and HI-PSGgold | Day 0 | ||
Secondary | The mean difference between RDI-CPAPflow and RDI-PSGgold | RDI-CPAPflow = Respiratory Disturbance Indices Determined Via Continuous Positive Airway Pressure RDI-PSGgold = Respiratory Disturbance Indices Determined by Polysomnography | Day 0 | |
Secondary | The standard deviation for the mean difference between RDI-CPAPflow and RDI-PSGgold | Day 0 | ||
Secondary | The mean difference between RERA-CPAPflow and RERA-PSGgold | RERA-CPAPflow = Respiratory Effort Related Arousals Determined Via Continuous Positive Airway Pressure RERA-PSGgold = Respiratory Effort Related Arousals Determined by Polysomnography | Day 0 | |
Secondary | The standard deviation for the mean difference between RERA-CPAPflow and RERA-PSGgold | Day 0 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05477719 -
Effect of Compression Stockings on the Number of Apneas/Hypopneas Per Hour of Sleep in Patients With Syndrome Obstructive Sleep Apnea/Hypopnea as Compared to no Treatment
|
N/A | |
Completed |
NCT04979234 -
A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome
|
N/A | |
Terminated |
NCT02735694 -
Cycloserine in the Treatment of Sleep Apnea
|
Phase 1 | |
Active, not recruiting |
NCT02470182 -
Screening for Sleep Disordered Breathing With Minimally Obtrusive Sensors
|
||
Completed |
NCT02088723 -
Testing the Elevation as Sleep Apnea Treatment
|
N/A | |
Completed |
NCT01457014 -
Sleep Disordered Breathing and Chronic Pain
|
N/A | |
Completed |
NCT00860743 -
Respiratory and Autonomic Plasticity Following Intermittent Hypoxia
|
Early Phase 1 | |
Completed |
NCT00976417 -
Mechanisms of Action of Adaptive Servoventilation
|
N/A | |
Active, not recruiting |
NCT00371293 -
The Effects of Obesity and Obstructive Sleep Apnea on Inflammation and Heart Disease
|
N/A | |
Completed |
NCT00607893 -
Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea
|
N/A | |
Completed |
NCT00083798 -
Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland
|
N/A | |
Completed |
NCT00070681 -
Outcomes of Sleep Disorders in Older Men
|
Phase 3 | |
Completed |
NCT00089752 -
Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT00046670 -
Sleep Disordered Breathing, APOE, and Lipid Metabolism
|
N/A | |
Completed |
NCT00051363 -
Apnea Positive Pressure Long-Term Efficacy Study
|
Phase 3 | |
Completed |
NCT00031239 -
Sleep Apnea in Look AHEAD Participants - Ancillary to Look AHEAD
|
N/A | |
Completed |
NCT00006323 -
Neurobehavioral Consequences of Sleep Apnea in Children
|
N/A | |
Terminated |
NCT00006321 -
Neurocognitive Function in Snoring Children
|
N/A | |
Completed |
NCT00005511 -
SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea
|
N/A | |
Completed |
NCT00005275 -
Sleep Heart Health Study (SHHS) Data Coordinating Center
|
N/A |